TUXUMDON POLIKISTOZIDA ULTRATOVUSH TEKSHIRISHNING AHAMIYATI
Kalit so'zlar
https://doi.org/10.47390/3030-3133V1I2Y2023N01Kalit so'zlar
polikistik tuxumdon sindromi; ultratovush diagnostikasi, ultratovush mezonlari.Annotasiya
Tuxumdonlar polikistoz sindromi (TPS) tugʻish yoshidagi ayollarda endokrin kasalliklar bilan bogʻliq keng tarqalgan kasalliklardan biridir. TPS ning tarqalish darajasi ushbu sindromni tan olish uchun qoʻllaniladigan mezonlarni va populyatsiya namunasining xususiyatlarini baholash bilan bogʻliq. TPS ning erta tashxisi simptomlarni yengillashtirish, hayot sifatini yaxshilash va tugʻilish muammolarini aniqlashda muhim rol oʻynaydi. TPS tashxisi uchun ultratovush tekshiruvi (UTT) eng keng tarqalgan va samarali diagnostika usuli hisoblanadi. Maqolada TPS ni aniqlashda UTT ning ahamiyati haqida fikr yuritilingan.
Manbalar
Таниш Гул Ахмад, Main causes of polycystic ovarian syndrome in women of reproductive age, Доктор ахборотномаси № 2.2 (104)—2022; DOI: 10.38095/2181-466X-20221042-32-35
Г.Д. Матризаева Cиндром поликистозных яичников был и остаѐтся проблемой научной и практической медицины // Вестник врача, № 4, 2018. С.109-114.
Б. Б. Негмаджанов, М. Н. Адылова, А. Э. Абдуллаева, Г. Т. Раббимова, Ф. И. Ганиев, В. О. Ким Қин ва бачадон аплазиясида тухумдонлар поликистози синдроми // Доктор ахборотномаси, № 2 (99), 2021. С.161-
165. DOI: 10.38095/2181-466X-2021992-161-165
Birdak MA, Farguhar CM, White HO. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. // Ann J Intern Med. 1997,126:32.
Diamamati E, Kandar A, Chryssa R, Kouls .A survey of the polycystic ovary syndrome in the Greek Islan of Lebsos: Hormonal metabolic profile.- // J Pf. Clinical – Endocrin & metabol. 1999: 4006-4011.
Dunaif A. Hyperandrogenic Anovaulation ( P.C.O.S ) :A unique disorder of insulin action associated with an increased risk of NIDDM // AM J Med. 1995,98(1A) :336.
Falsett L, Efithrriou G. Hyper insulinemia in the polycystic ovary syndrome. A clinical endocrine and metabolic study in 240 patients. Gyn. // End. 1996. 10 :319-326.
Fitsch G, Hanzal R, Jensen D, Hacker N.F. Endometrial cancer in premenopausal women 45 years and younger.//Obstect- Gynecol , 2015, 85: 504.
Frank . S. Polysystic ovary syndrome.// New Eng1 J Med. 2016, 333:853-854.
Jahafar S, Eden J.A, Waren P, Sepplam Ngvyen T.V. A twin study of polycystic ovary syndrome // Fertil-Steril,
1995,63:78-478.
Kinara I, Togasgi K, Kawakan s, Nakanoy, Takakora K, Mori T, Konish J, Polycystic ovaries :Implications of Diagnosis with MRI imaging // Radiology. 1996.201:549.
Leon S, Robert H. Glass, Nathan G.klse. Clinical gynecologic endocrinology infertility./ 6th ed. Lippincott Williams & Wilkins 2018, 487 -523.
Suterlin M, Steck T. Sensitivity of plasma insulin level in obese and non obese women with functional hyper androgenism. //Gyn-End.2017,9:34-44.
Wild RA, Alaupovic P, Parker IJ. Lipid and Apolipoprotein abnormalities in hirsute women and association with insulin resistance .// Am J Obstet Gynecol. 1992,166:1191.
Azziz R. Polycystic Ovary Syndrome. Obstet Gynecol. 2018; 132(2): 321-336. doi: 10.1097/AOG.0000000000002698.
Meier RK. Polycystic Ovary Syndrome. Nurs Clin North Am. 2018; 53(3): 407-420. doi: 10.1016/j.cnur.2018.04.008.
Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012; 27(10): 3067-3073.
Chen X, Yang D, Mo Y, Li L, Chen Y, Huang Y. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol. 2008; 139(l): 59-64.
Huraseva AB, Konoplya AA, Akkuan AA, Brimpong BB, Svyatchenko KS. An overview of the leading symptoms and phenotypes of polycystic ovary syndrome among different races. Regional’nyj vestnik. 2018; 4(13): 2-5. Russian (Хурасева А.Б., Конопля А.А., Аккуан А.А., Бримпонг Б.Б., Святченко К.С. Обзор ведущих симптомов и фенотипов синдрома поликистозных яичников среди различных рас //Региональный вестник. 2018. № 4(13). С. 2-5.)
Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JS, Legro RS. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015; 36(5): 487-525. https://doi. org/10.1210/er.2015-1018.
